Neurobiology of Disease: Volume 133 to Volume 146
Neurobiology of Disease stands as a prominent international open access journal that bridges the realms of fundamental and clinical neuroscience. Positioned at the confluence of these two domains, the journal serves as a platform for disseminating cutting-edge research that explores the intricate connections between molecular, cellular, and clinical aspects of neurological disorders.
At its core, the journal seeks to unravel the molecular and cellular underpinnings of disease mechanisms. By delving into the intricate workings of neural systems and their connections to behavioral disorders, the journal offers insights that contribute to a deeper comprehension of the complex interplay between the nervous system and disease.
Neurobiology of Disease serves as a venue for scholarly exploration of various facets of neurological and psychiatric disorders. Genetics, a pivotal facet of understanding inherited neurological and psychiatric diseases, finds its place in the journal’s pages. Additionally, the journal dedicates attention to the critical realm of nervous system aging, shedding light on the intricate processes that unfold as the nervous system evolves over time.
While the journal recognizes the importance of advancing therapeutic interventions, it emphasizes that the development of new therapies must be grounded in the generation of significant new knowledge. As such, the validation of putative therapeutics without substantial contributions to the understanding of the neurobiology underlying the specific condition is deemed inappropriate for inclusion.
In this dynamic and multidisciplinary journal, researchers and clinicians find an avenue to share their findings, from molecular insights to clinical applications. By fostering the exchange of knowledge and ideas across the spectrum of neurobiology and disease, Neurobiology of Disease contributes to the advancement of both our theoretical understanding and practical approaches to managing neurological disorders.
Discovery and development of better medical countermeasures for chemical threats targeting the nervous system
Volume 133, January 2020
Reviews
There are no reviews yet.